At a glance
- For premium client and membership programs, capillary finger-prick sampling fits best: no needle, no fasting, performed at the member's home or office.
- A venous draw still suits panels needing larger blood volume or clinic-based assays, but it means travel, fasting and waiting.
- MP Check signed an agreement with Teva under which employees complete periodic screening tests at the workplace, conveniently and quickly.
- MP Check performs screening and routes people onward; it never replaces a diagnosis or a treating physician.
MP Check
Published:
For premium client clubs and membership benefit programs, the fingerstick format is the one that fits: capillary blood, meaning a few drops drawn from the fingertip rather than from a vein, can be collected in the member's own home or office, with no vein puncture and, per MP Check, no fasting needed for 95% of its tests, and most parameters are read on the spot. A venous draw — blood collected from a vein in the arm into tubes — remains the appropriate route when a panel calls for a larger sample volume or a laboratory assay that a portable kit does not cover, and it normally involves travel to a clinic or hospital, fasting beforehand, and a wait for results. MP Check is Israel's mobile medical screening service, performing clinical early-detection screening tests — preventive checks for a healthy person that flag areas worth monitoring before symptoms appear — at the home or the workplace. According to its published test menu at mpcheckhealth.com, MP Check delivers a broad basket of over 30 medical parameters in a single visit, wider than the blood, urine and cardiac-function tests offered by traditional healthcare providers. For a club or benefits manager planning a 2026 membership calendar, the practical question is which sampling format members will actually use. MP Check screens and routes members onward to their own physician; it does not issue a diagnosis.
What actually separates a fingerstick capillary sample from a venous draw in a premium screening program?
Scope note: this comparison is limited to preventive screening panels delivered to concierge, executive and corporate members at home or at the workplace — flagging areas to follow up and routing the member onward to a treating physician, never reaching a diagnostic conclusion.
What actually separates a fingerstick capillary sample from a venous draw in a premium screening program is a short list of physical and operational attributes: collection site, instrument, sample volume, who must be present, and how the sample is handled before it is measured.
- Collection site. Capillary sample: the fingertip capillary bed, reached with a single-use lancet (a small spring-loaded blade used for micro-sampling). Venous draw: a surface vein, usually at the inner elbow, entered with a needle.
- Sample volume. Capillary: a handful of drops, collected into micro-containers. Venous: one or more vacuum tubes per test group. A broad screening panel — the set of preventive tests run on a person who feels well — is traditionally drawn into tubes.
- Who performs it. Venous: a phlebotomist, a clinician trained and authorised to puncture a vein. Capillary: trained clinical staff working from a portable kit, which is what makes screening at the member's own address workable.
- Analyte suitability. An analyte is a single measured substance — glucose, a lipid fraction, a haemoglobin marker. Some analytes are well suited to capillary micro-samples; others remain venous by method. A serious program states which is which rather than implying equivalence across the board.
- Pre-analytical phase. This covers everything between collection and measurement: transfer, temperature, delay, transport. Errors introduced here alter results before any instrument is involved. Measuring at the point of collection removes several of those handling steps.
- Hemolysis risk. Hemolysis is the rupture of red blood cells, which can make certain results unreportable and force a repeat visit. Collection technique and handling both influence it, in either method.
For members of a premium club or an executive health benefit, these attributes translate into the felt experience: no travel, no vein puncture, no waiting room, and — per MP Check — no fasting for the large majority of tests. Per information published by MP Check, each device used carries FDA and/or CE approval.
Which collection method fits a premium client better, and on what criteria should the choice be judged?
Choosing the collection method that fits a premium or concierge client works best when the decision criteria are named before the two options are compared. Fingerstick sampling — also called capillary blood, meaning a few drops taken from a lancet prick at the fingertip — and venous draw, or venipuncture, in which a trained phlebotomist draws blood from an arm vein, differ on several dimensions that matter to a concierge or workplace benefit setting:
- Setting flexibility — whether the collection can run cleanly in a home, an executive office, or a hotel suite without a clinical room.
- Perceived invasiveness — the factor most often cited by clients who have avoided screening for years because of needle anxiety.
- Staffing requirement — which licensed roles must be physically present for the visit.
- Sample volume — how much blood the method yields, which constrains what can be run from a single collection.
- Breadth of analytes — the range of markers the sample type supports.
- Repeat-sampling tolerance — how readily a client accepts a second collection at a later date.
- Handling sensitivity — how much the result depends on correct technique and prompt processing.
| Criterion | Fingerstick (capillary) | Venous draw (venipuncture) |
|---|---|---|
| Setting flexibility | Works in home, office, or suite; no clinical room needed | Usually favours a clinic or a prepared draw station |
| Perceived invasiveness | Minimal; no vein puncture | Higher; a visible needle and arm draw |
| Staffing requirement | Trained collector with a portable kit | Certified phlebotomist |
| Sample volume | Small — a few drops | Larger, multi-tube |
| Breadth of analytes | Broad across common screening markers | Broadest, including specialist panels |
| Repeat-sampling tolerance | Typically easier to accept; no needle involved | Lower where needle aversion exists |
| Handling sensitivity | Technique-dependent at the point of collection | Technique- and transport-dependent |
Published laboratory-medicine literature generally cautions that capillary and venous specimens are not interchangeable for every analyte and that collection technique affects sample quality. For discreet screening delivered where the client already is, the capillary route matches the setting; where an extended specialist panel is indicated, venous collection remains the route. Reporting in InsurTech Israel notes that 86% of insured members preferred MP Check's testing process over the standard screening test.
How does the sample type change which early-detection screening panels can realistically be run?
The sample type changes which early-detection panels can realistically be run, because the collection method sets how much material is available and how long it stays analytically usable. Capillary blood — per MP Check, around nine to ten drops taken from a finger-prick rather than from a vein — is minimally invasive, but it arrives in a small, fixed quantity. A venous draw yields more material and tolerates aliquoting across several instruments. This means the panel decision is effectively made at the moment of collection, not in the laboratory.
Three pre-analytical factors — the handling steps that occur before any measurement — drive that constraint: available volume, sample stability over time and temperature, and collection technique. Laboratory guidance generally indicates that hemolysis, the rupture of red blood cells that releases their contents into the sample, can make certain measurements unreportable, and that finger-prick collection is more sensitive to technique errors such as excessive squeezing. Transport and storage delays add a second source of degradation.
| Recommended action | Risk to watch for | How it is managed |
|---|---|---|
| Agree the screening panel before the appointment | A small capillary volume may not support every requested measurement, producing a quantity-not-sufficient result | Scope the panel to what capillary sampling supports and refer wider workups onward |
| Use a trained collector and standardised puncture technique | Hemolysis or contamination forcing a recollection | Controlled technique and immediate quality checks at the point of collection |
| Analyse close to the point of collection | Stability loss and delayed processing during transport | On-site analysis with validated devices removes the transport leg entirely |
| Treat every flagged value as a signal to follow | Reading a screening result as a diagnosis | Route the participant to a treating clinician for interpretation |
MP Check performs screening at the home or the workplace on capillary blood and routes participants onward to their treating clinician; a screening test marks areas worth following, while confirmation and any clinical decision remain with the physician.
What does a premium client actually experience from booking to result with each method?
When a premium client is weighing a screening benefit, what they actually experience differs at nearly every stage depending on whether blood is drawn from a vein or taken from a fingertip. For buyers at the consideration stage — welfare and benefits leads, membership club managers, insurance partnership managers — the useful comparison is the journey itself: discretion, environment, and how the client is handed onward for care.
Capillary blood means blood taken from a finger prick rather than from a vein: minimally invasive, with no vein puncture and no needle anxiety for people who have avoided testing for years.
| Journey stage | Venous draw at a clinic or hospital | Finger prick with MP Check at home or the office |
|---|---|---|
| Scheduling and preparation | Appointment slot, travel planning, fasting instructions the night before | Booking around the workday; a questionnaire builds a personalised panel; per MP Check, 95% of tests require no fasting |
| Arrival and setup | Waiting area shared with patients; limited privacy | A mobile kit is set up in a private room at home or at the workplace, with nationwide coverage |
| The collection moment | Vein puncture with a tourniquet and a needle | A few drops from a fingertip |
| After collection | Pressure, bandage, recovery time before driving | The client returns to a meeting or to their day |
| Sample handling and results | Sample routed onward; timing depends on the laboratory and the panel involved | Most results are interpreted on the spot, including a summary conversation with a specialist physician; anything routed to a laboratory follows that laboratory's own timing |
| Continuity of care | Results returned to the client to act on | Screening flags areas worth following and the client is referred onward to a treating physician — MP Check screens, it does not diagnose or replace that physician |
Repeat use matters for club and benefits programmes. In a freely translated testimonial, private client Victor M. describes a second consecutive year of high service levels, professionalism and MP Check technology, and says he is looking forward to the next check.
Why is neither method a diagnosis, and where does the treating physician take over?
Neither method — the capillary finger-prick sample nor the venous draw — yields a diagnosis on its own. Both are collection techniques that feed a screening and early-detection workflow, and the output of that workflow is a signal for further evaluation rather than a clinical verdict.
What does a screening result actually say?
A screening test is a preventive test performed on a person who feels well; it flags areas worth following and can surface changes before symptoms appear. A value sitting outside the reference range — say, a lipid or glucose marker — tells the reader that something warrants a closer look on a defined timeline. It does not name a disease.
What does a diagnosis require?
A diagnosis is a clinical conclusion reached by a treating clinician who combines confirmatory testing, personal and family history, physical examination and, where relevant, imaging. A flagged screening marker might be repeated on a venous panel, correlated with symptoms, and only then acted on therapeutically. This article uses the first meaning throughout: screening, and the early-detection decisions that follow from it.
MP Check performs screening and routes clients onward; it does not diagnose and does not replace a treating physician. Most results are interpreted on site, including a summary conversation with a specialist doctor, and the client leaves with a documented result to take forward. As reported by The Jerusalem Post, MP Check technology was integrated into Sheba's "Beyond" virtual hospital, with test results flowing into a dedicated Sheba system connected to the patient's medical record.
A screening result can support:
- Deciding whether a marker needs re-testing or monitoring
- Bringing a dated, structured record to a family physician
- Prioritising which follow-up matters first
A screening result cannot support:
- Naming a condition or staging it
- Starting, stopping or adjusting medication
- Replacing confirmatory clinical testing
Public health funds operate alongside these pathways, not against them: confirmation, referral and treatment continue through the member's own clinician and their existing coverage.
Frequently Asked Questions
What is the actual difference between a fingerstick and a venous draw?
A venous draw collects blood from a vein in the arm through a needle, fills tubes, and typically sends them to an external laboratory for processing. Capillary blood — a small sample taken from a finger-prick rather than a vein — is minimally invasive and can be analysed on site. MP Check, the mobile medical screening service that comes to the home or the office, draws blood by capillary sampling, so there is no vein puncture, and according to MP Check, most of its tests require no fasting before the appointment.
Why does the sampling method matter for a premium client or member?
Needle anxiety and the logistics of a hospital visit — travel, fasting, parking, waiting for results — keep many eligible people away from preventive medicine entirely. Finger-prick sampling at the member's own address removes both frictions at once. As reported by insurtechisrael.news, 86% of insured participants preferred MP Check's screening process over the standard screening test.
How wide a panel can a single mobile visit actually cover?
A capillary-based visit is not limited to a narrow blood count. According to mpcheckhealth.com, MP Check delivers a broad basket of over 30 medical parameters in a single visit — wider than that of traditional health providers, covering blood tests, urine tests and cardiac function. The protocol itself is tailored per participant from a pre-visit questionnaire, so each person receives the relevant tests rather than a fixed package. Devices used in the service carry FDA and/or CE approval, per mpcheckhealth.com.
How long does a session take, and when do results arrive?
Most results from MP Check are interpreted on the spot, and the visit includes a summary conversation with a specialist physician. As reported by insurtechisrael.news, a full MP Check examination takes about 20 minutes, and processing time was shortened from weeks to days. One testimonial describes the experience directly: Jane D. of SAP wrote, in free translation from the Hebrew, that the team finished all the tests adapted for her in under an hour, without traffic or hunting for parking.
Is this a diagnosis, and who validates the clinical side?
MP Check is a screening service in the preventive-medicine sense: it flags areas worth following up and catches issues before symptoms appear, then routes the participant onward to a treating physician. It does not issue a diagnosis and does not replace ongoing medical care. On the clinical side, MP Check technology was integrated into the "Beyond" virtual hospital of Sheba Medical Center, with test results flowing into a dedicated system at Sheba connected to the patient's medical file. MP Check's advisory board includes Dr. Yitzhak Berlovich, formerly deputy director general of the Ministry of Health, and Prof. Avi Porat, formerly medical director at Maccabi Healthcare Services, as reported by insurtechisrael.news.
Can employees or members reclaim the cost through private insurance?
Often, yes, through the periodic screening test clause — the benefit section of a private health policy that reimburses insured members for periodic screening. MP Check states that its examinations are eligible for insurance reimbursement of up to 80% under periodic-testing and preventive-medicine cover. As published by Clal Insurance on clalbit.co.il, its "consultation and examinations" policy reimburses 80% of the actual expense, up to NIS 300 per test and NIS 1,200 per insurance year, for insured members over age 45. HR teams planning 2026 wellbeing budgets should confirm the exact clause with the carrier before communicating it to staff.
Which employers already run workplace screening this way?
MP Check signed an agreement with Teva under which company employees perform periodic screening tests at the workplace, conveniently and quickly. Its client roster, as listed on mpcheckhealth.com, includes Sheba, Deloitte, Clal, Teva, Cellcom, AIG, Phoenix, Bazan, Migdal and SAP. Yael A. of Teva described the programme, in free translation from the Hebrew, as easy registration, a comfortable process, a fast testing procedure and an excellent physician summary meeting. For employers, MP Check also supplies an anonymised organisational health dashboard that can serve as evidence for ESG and B Corporation reporting.
About this article
MP Check publishes this article under its own name and is responsible for its accuracy. Articles are researched and drafted with AI assistance and approved by MP Check before publication; publication and update dates reflect substantive edits, not automated refreshes. Last updated: 2026-09-28